Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.650
+0.070 (1.96%)
May 18, 2026, 4:00 PM EDT - Market closed
Myriad Genetics Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$6.83
Upside
+87.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +64.38% | May 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5.5 | Hold | Maintains | $6 → $5.5 | +50.68% | May 6, 2026 |
| UBS | UBS | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +64.38% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6.5 → $6 | Hold | Maintains | $6.5 → $6 | +64.38% | Feb 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8.5 | Buy | Maintains | $9 → $8.5 | +132.88% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | +78.08% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +146.58% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $6 → $8 | Hold | Maintains | $6 → $8 | +119.18% | Nov 4, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $20 → $6 | Buy → Hold | Downgrades | $20 → $6 | +64.38% | May 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $9 | Buy | Maintains | $13 → $9 | +146.58% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $22 → $6 | Buy → Hold | Downgrades | $22 → $6 | +64.38% | May 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +119.18% | May 7, 2025 |
| UBS | UBS | Hold Maintains $16 → $7 | Hold | Maintains | $16 → $7 | +91.78% | May 7, 2025 |
| Raymond James | Raymond James | Buy Reiterates $19 → $10 | Buy | Reiterates | $19 → $10 | +173.97% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +283.56% | Apr 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.